Encompass Health Corporation Financials

Market Capitalization $9.60 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.42
Forward PE	19.93
Price to Sales TTM	$1.84
Price to Book MRQ	$4.90
Enterprise to Revenue	2.50
Enterprise to EBITDA	11.58

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.10%
Operating Margin	15.48%
Return on Assets TTM	8.38%
Return on Equity TTM	22.92%

Income Statement

Revenue TTM	$5,215,000,064
Revenue per Share TTM	$52.26
Quarterly Revenue Growth	11.90%
Gross Profit TTM	$2,159,200,000
EBITDA	$1,144,400,000
Net Income to Common TTM	$431,500,000
Diluted EPS TTM	$4.25
Quarterly Earnings Growth YoY	26.80%

Balance Sheet

Total Cash MRQ	$147,800,000
Total Cash per Share MRQ	$1.47
Total Debt MRQ	$
Total Debt to Equity MRQ	102.71
Current Ratio MRQ	1.04
Book Value per Share MRQ	$19.44

Cash Flow

Operating Cash Flow TTM	$925,000,000
Levered Free Cash Flow TTM	$103,550,000

EHC Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	100,750,000
Float Shares	99,290,693
Avg 10 Volume	473,490
Avg 30 Volume	None
Shares Short	1,353,327
Short Ratio	2.19
Short % of Shares	1.52%
% Held by Insiders	1.31%
% Held by Institutions	98.47%

Stock Price Summary

Beta	0.78
Fifty Two Week Low	$70.74
Fifty Two Week High	$104.55
Fifty Two Week Change	25.14%
Day 50 MA	$97.54
Day 200 MA	$91.07

Dividends and Splits

Forward Annual Dividend Rate	$0.68
Forward Annual Dividend Yield	0.71%
Trailing Annual Dividend Rate	$0.64
Trailing Annual Dividend Yield	0.67%
Payout Ratio	14.59%
Dividend Date	2025-01-15
Ex Dividend Date	2025-01-02
Last Split Factor
Last Split Date	2022-07-01